Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001178253-25-000007
Filing Date
2025-10-21
Accepted
2025-10-21 08:00:08
Documents
1
Period of Report
2025-10-17

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3157
  Complete submission text file 0001178253-25-000007.txt   4571
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Issuer) CIK: 0001178253 (see all company filings)

EIN.: 562181648 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302
Business Address
Angulo Gonzalez David (Reporting) CIK: 0001644071 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36365 | Film No.: 251405385